Reviewing United American Healthcare (OTCMKTS:UAHC) & BrainsWay (NASDAQ:BWAY)

United American Healthcare (OTCMKTS:UAHC) and BrainsWay (NASDAQ:BWAY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares United American Healthcare and BrainsWay”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United American Healthcare	N/A	N/A	$720,000.00	N/A	N/A
BrainsWay	$31.78 million	6.54	-$4.20 million	$0.10	110.51

United American Healthcare has higher earnings, but lower revenue than BrainsWay.

Insider and Institutional Ownership

30.1% of BrainsWay shares are held by institutional investors. 14.3% of United American Healthcare shares are held by company insiders. Comparatively, 19.0% of BrainsWay shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares United American Healthcare and BrainsWay’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United American Healthcare	N/A	N/A	N/A
BrainsWay	3.88%	3.52%	2.26%

Analyst Recommendations

This is a summary of current ratings and target prices for United American Healthcare and BrainsWay, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United American Healthcare	0	0	0	0	0.00
BrainsWay	0	0	3	0	3.00

BrainsWay has a consensus target price of $13.17, indicating a potential upside of 19.16%. Given BrainsWay’s stronger consensus rating and higher probable upside, analysts clearly believe BrainsWay is more favorable than United American Healthcare.

Volatility and Risk

United American Healthcare has a beta of -1.29, suggesting that its stock price is 229% less volatile than the S&P 500. Comparatively, BrainsWay has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500.

Summary

BrainsWay beats United American Healthcare on 10 of the 11 factors compared between the two stocks.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.